MEB 12.5% 0.9¢ medibio limited

249D to fail, page-18

  1. 173 Posts.
    lightbulb Created with Sketch. 40

    @Bear10, you seem to know a lot about meb.


    “Seemsto me they should drop anything except growth of the biometrics part and try topartner in with others by selling the biometric and not an overall psych app.”


    Shame you didn’t make that known to management atthe time of the VC acquisition, which given your knowledge of the company, Iknow you could have done.  There musthave been other forces at play at that time I guess.


    I wouldn’t be so pessimistic about the time a new ceo willneed to come up to speed.  The science iscomplex but the commercialization strategy is not. 

 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.